Petros
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1185 Avenue of the Americas Fl 3, New Yo...Phone Number
(973) 242-0005Website
www.petrospharma.comRevenue
$5.1 MillionStock Symbol
PTPIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Petros
Petros Pharmaceuticals is a pharmaceutical research and development company focused on conditions in men's health such as erectile dysfunction and acute Peyronies disease. They are headquartered in New York, New York.Explore more
Petros Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Petros your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Petros recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Petros has new funding data
Congratulate Masked Content for being promoted to Masked Content at Petros
Check if Petros has recently received funding, and reach out quickly before it becomes old news!
Click to see if Petros had a recent Job posting/layoffs
Check out if Petros is spiking on competitors!
Product Launch: Get notified when Petros launches new products
Petros, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Petros as Masked Content
Find more new buyers
Compare Similar Companies to Petros
Compare insights from companies similar to Petros, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Petros is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Petros is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Petros.
Petros financials insights
Gather financial insights about Petros, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$15M
Petros Tech Stack
A closer look at the technologies used by Petros
See more technologies
Most Recent Scoops
Earnings
Financial Planning, Product Management, Customer Service
Earnings
Earnings
Earnings
Product Marketing, Product Development, Product Launch, Financial Planning, Funding, Product Management, Sales, Sales Development
Earnings
Product Development
Petros News & Media
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of Petros Pharmaceuticals, said the company aims to expand access of key prescription pharmaceuticals as over-the-counter (OTC) treatment options. Boctor added that Petros is a pure play in the Rx-to-OTC self-care market, focused on bringing its current lead erectile dysfunction (ED) therapeutic OTC whilLemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activity Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activityPetros Pharmaceuticals slips on $15M private placement financing (NASDAQ:PTPI)
Petros Pharmaceuticals (PTPI) shares slipped -9.3% in early trading on Friday after the company said it had secured $15M private placement financing. The micro-cap health company said...Petros Pharmaceuticals Secures $15 Million Private Placement Financing - MarketScreener
-- Petros Pharmaceuticals said late Thursday it has secured a $15 million private placement financing led by its largest shareholders. The company intends to use the proceeds to support its...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Petros
Sign Up For FreeTo access detailed company insights
Petros Pharmaceuticals is a pharmaceutical research and development company focused on conditions in men's health such as erectile dysfunction and acute Peyronies disease. They are headquartered in New York, New York.... Read More
